![]() |
![]() |
My Amedeo
![]() ![]() ![]() |
![]() |
|||||||||
The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al. |
Prostate Cancer |
Free Subscription
2 Anticancer Res |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Prostate Cancer is free of charge.
Bladder Volume <200 ml During a Course of Moderate Hypofractionated Irradiation
in Patients With Localized Prostate Cancer.
Anticancer Res. 2025;45:701-708.
PubMed
Abstract available
Prognostic Stratification Using Early Prostate-specific Antigen Kinetics in Men
With Metastatic Hormone-sensitive Prostate Cancer.
Anticancer Res. 2025;45:751-759.
PubMed
Abstract available
Refining partial gland ablation for localised prostate cancer: the FALCON
project.
BJU Int. 2025 Feb 4. doi: 10.1111/bju.16669.
PubMed
Abstract available
Role of (18)F-PSMA-1007 PET/CT-derived quantitative volumetric tumor parameters
in cytoreductive radical prostatectomy selection for patients with low-volume
metastatic hormone-sensitive prostate cancer: a retrospective study.
BMC Cancer. 2025;25:192.
PubMed
Abstract available
Use of erectile dysfunction treatments after prostate cancer treatment and their
perceived impact on men's sex life: an analysis of patient reported outcome
survey data.
BMC Urol. 2025;25:21.
PubMed
Abstract available
Elevated serum levels of GPX4, NDUFS4, PRDX5, and TXNRD2 as predictive biomarkers
for castration resistance in prostate cancer patients: an exploratory study.
Br J Cancer. 2025 Feb 3. doi: 10.1038/s41416-025-02947.
PubMed
Abstract available
Dietary intake of isoflavones and coumestrol and risk of pancreatic cancer in the
prostate, lung, colorectal, and ovarian cancer screening trial.
Br J Cancer. 2024 Dec 16. doi: 10.1038/s41416-024-02929.
PubMed
Abstract available
JMJD6 Rewires ATF4-Dependent Glutathione Metabolism to Confer Ferroptosis
Resistance in SPOP-Mutated Prostate Cancer.
Cancer Res. 2025 Feb 4. doi: 10.1158/0008-5472.CAN-23-2796.
PubMed
Abstract available
Impact of software-assisted structured reporting on radiology residents
approaching prostate MRI.
Eur J Radiol. 2024;183:111889.
PubMed
Abstract available
Automated 24-sector grid-map algorithm for prostate mpMRI improves precision and
efficacy of prostate lesion location reporting.
Eur J Radiol. 2025;183:111897.
PubMed
Abstract available
ESR Bridges: next-generation imaging in prostate cancer-a multidisciplinary view.
Eur Radiol. 2025 Jan 31. doi: 10.1007/s00330-025-11354.
PubMed
Long-term Outcomes and Prognostic Impact of Residual Cancer Burden After
Intensified Neoadjuvant Therapy in High-risk Prostate Cancer.
Eur Urol. 2025 Feb 6:S0302-2838(25)00027-2. doi: 10.1016/j.eururo.2025.
PubMed
Abstract available
PARP Inhibitors and Prostate Cancer: The Struggle To Separate the Grain from the
Chaff.
Eur Urol. 2025 Feb 3:S0302-2838(25)00024-7. doi: 10.1016/j.eururo.2025.
PubMed
Intraductal Carcinoma and Cribriform Pattern in Prostate Cancer: Challenges and
Emerging Perspectives.
Eur Urol. 2025 Jan 30:S0302-2838(25)00025-9. doi: 10.1016/j.eururo.2025.
PubMed
Abstract available
[Retracted] Zinc finger protein?like 1 is a novel neuroendocrine biomarker for
prostate cancer.
Int J Oncol. 2025;66:16.
PubMed
Abstract available
Patterns of relapse following radiotherapy of intermediate-risk (IR) prostate
cancer (PCa) on the PROFIT randomized trial.
Int J Radiat Oncol Biol Phys. 2025 Feb 4:S0360-3016(25)00089.
PubMed
Abstract available
Image-Guided Brachytherapy for Pediatric Bladder and/or Prostate
Rhabdomyosarcoma: Toward an Increased Personalization of Treatment.
Int J Radiat Oncol Biol Phys. 2025;121:658-666.
PubMed
Abstract available
Online Adaptive Proton Therapy Facilitated by Artificial Intelligence-Based
Autosegmentation in Pencil Beam Scanning Proton Therapy.
Int J Radiat Oncol Biol Phys. 2025;121:822-831.
PubMed
Abstract available
Is the Imaging Radiation Oncology Core Head and Neck Credentialing Phantom an
Effective Surrogate for Different Anatomic Sites?
Int J Radiat Oncol Biol Phys. 2025;121:811-821.
PubMed
Abstract available
Hypoxia-Associated Gene Signatures Are Not Prognostic in High-Risk Localized
Prostate Cancers Undergoing Androgen Deprivation Therapy With Radiation Therapy.
Int J Radiat Oncol Biol Phys. 2025;121:752-760.
PubMed
Abstract available
An Aggressive Approach for Mucinous Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2025;121:584.
PubMed
Overuse of imaging in prostate cancer staging.
Int J Urol. 2025 Feb 3. doi: 10.1111/iju.70003.
PubMed
Abstract available
Risk factors for rectal wall infiltration in hydrogel spacer placement: Influence
of biopsy approach.
Int J Urol. 2025;32:183-189.
PubMed
Abstract available
Iodine-125 low-dose rate prostate brachytherapy.
Int J Urol. 2025;32:130-137.
PubMed
Abstract available
Safety, Dosimetry, and Feasibility of [(68)Ga]Ga-PSMA-R2 as an Imaging Agent in
Patients with Biochemical Recurrence or Metastatic Prostate Cancer.
J Nucl Med. 2025 Feb 6:jnumed.124.268318. doi: 10.2967/jnumed.124.268318.
PubMed
Abstract available
(99m)Tc-MIP-1404 SPECT/CT Companion Diagnostic for (177)Lu-PSMA Therapy in
Metastatic Castration-Resistant Prostate Cancer.
J Nucl Med. 2025 Feb 6:jnumed.124.269319. doi: 10.2967/jnumed.124.269319.
PubMed
Abstract available
Exploring the Flare Phenomenon in Patients with Castration-Resistant Prostate
Cancer: Enzalutamide-Induced PSMA Upregulation Observed on PSMA PET.
J Nucl Med. 2025 Feb 6:jnumed.124.268340. doi: 10.2967/jnumed.124.268340.
PubMed
Abstract available
Diuresis During (18)F-Flotufolastat (rhPSMA-7.3) PET/CT Improves Recurrence
Detection After Prostatectomy: A Prospective Phase II Trial.
J Nucl Med. 2025 Jan 23:jnumed.124.268574. doi: 10.2967/jnumed.124.268574.
PubMed
Abstract available
Comparative transcriptomics reveals a mixed basal, club, and hillock epithelial
cell identity in castration-resistant prostate cancer.
Proc Natl Acad Sci U S A. 2025;122:e2415308122.
PubMed
Abstract available
Urinary Leakage after Robot-Assisted Radical Prostatectomy: Is Always Predictive
of Functional Results?
Urol Int. 2025;109:68-73.
PubMed
Abstract available
Implementing and Optimizing Universal Germline Genetic Testing for Patients with
Prostate Cancer in Clinical Practice Consider.
Urology. 2025 Feb 3:S0090-4295(25)00114-1. doi: 10.1016/j.urology.2025.
PubMed
Abstract available
Aquablation Safety and Outcomes Among Men with Prostate Cancer.
Urology. 2025 Jan 30:S0090-4295(25)00107-4. doi: 10.1016/j.urology.2025.
PubMed
Thank you for your interest in scientific medicine.